home

 

Providing Targeted Cancer Diagnostics

News

UCL-AD Adopts Roche Companion Diagnostics Testing Platform

UCL-AD has chosen to adopt Roche Pathway HER2 (4B5) and Inform HER2 DDISH on the Benchmark ULTRA automated staining system for use in breast and gastric cancer HER2 testing applications.